Skip to main content Accessibility help
×
Home

Prevalence, incidence and persistence of ADHD drug use in Japan

  • Y. Okumura (a1) (a2), M. Usami (a3), T. Okada (a4), T. Saito (a5), H. Negoro (a6), N. Tsujii (a7), J. Fujita (a8) and J. Iida (a9)...
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Prevalence, incidence and persistence of ADHD drug use in Japan
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Prevalence, incidence and persistence of ADHD drug use in Japan
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Prevalence, incidence and persistence of ADHD drug use in Japan
      Available formats
      ×

Abstract

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

*Address for correspondence: Y. Okumura, Department of Psychiatry and Behavioral Science, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan. (Email: yokumura@blue.zero.jp)

References

Hide All
Bachmann, CJ, Philipsen, A, Hoffmann, F (2017). ADHD in Germany: trends in diagnosis and pharmacotherapy. Deutsches Ärzteblatt International 114, 141148.
Beau-Lejdstrom, R, Douglas, I, Evans, SJ, Smeeth, L (2016). Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence. BMJ Open 6, e010508.
Bonati, M, Reale, L, Zanetti, M, Cartabia, M, Fortinguerra, F, Capovilla, G, Chiappedi, M, Costantino, A, Effedri, P, Luoni, C, Martinelli, O, Molteni, M, Ottolini, A, Saccani, M, Lombardy, AG (in press). A regional ADHD center-based network project for the diagnosis and treatment of children and adolescents with ADHD. Journal of Attention Disorders.
Burcu, M, Zito, JM, Metcalfe, L, Underwood, H, Safer, DJ (2016). Trends in stimulant medication use in commercially insured youths and adults, 2010–2014. JAMA Psychiatry 73, 992993.
Furu, K, Karlstad, O, Zoega, H, Martikainen, JE, Bahmanyar, S, Kieler, H, Pottegard, A (2017). Utilization of stimulants and atomoxetine for attention-deficit/hyperactivity disorder among 5.4 million children using population-based longitudinal data. Basic & Clinical Pharmacology & Toxicology 120, 373379.
Kovess, V, Choppin, S, Gao, F, Pivette, M, Husky, M, Leray, E (2015). Psychotropic medication use in French children and adolescents. Journal of Child and Adolescent Psychopharmacology 25, 168175.
Kubo, S, Noda, T, Myojin, T, Nishioka, Y, Higashino, T, Matsui, H, Kato, G, Imamura, T (2018). National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB): Outline and patient-matching technique. https://www.biorxiv.org/content/biorxiv/early/2018/03/29/280008.full.pdf (accessed 10 April 2018).
Lawson, KA, Johnsrud, M, Hodgkins, P, Sasane, R, Crismon, ML (2012). Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clinical Therapeutics 34, 944956, e4.
Ministry of Health, Labour and Welfare (2013). On the use of the National Database of Health Insurance Claim Information and Specified Medical Checkups (in Japanese). http://www.mhlw.go.jp/stf/shingi/2r9852000002ss9z-att/2r9852000002ssfg.pdf. Accessed 4 December 2017.
Ministry of Internal Affairs and Communications (2015). Population Estimates in 2014: Table 1: Population by Age (Single Year), Sex and Sex ratio (in Japanese). https://www.e-stat.go.jp/stat-search/files?page=1&layout=datalist&stat_infid=000029025950&lid=000001132435. Accessed 1 January 2018.
National Institute for Health and Care Excellence (2006). Methylphenidate, Atomoxetine and Dexamfetamine for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents. British Psychological Society: Leicester.
National Institute for Health and Care Excellence (2018). Attention Deficit Hyperactivity Disorder: Diagnosis and Management. British Psychological Society: Leicester.
Okumura, Y, Sakata, N, Takahashi, K, Nishi, D, Tachimori, H (2017). Epidemiology of overdose episodes from the period prior to hospitalization for drug poisoning until discharge in Japan: an exploratory descriptive study using a nationwide claims database. Journal of Epidemiology 27, 373380.
Palli, SR, Kamble, PS, Chen, H, Aparasu, RR (2012). Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 22, 139148.
Piovani, D, Clavenna, A, Cartabia, M, Bonati, M (2016). Psychotropic medicine prescriptions in Italian youths: a multiregional study. European Child & Adolescent Psychiatry 25, 235245.
Polanczyk, GV, Salum, GA, Sugaya, LS, Caye, A, Rohde, LA (2015). Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. Journal of Child Psychology and Psychiatry, and Allied Disciplines 56, 345365.
Saito, M (2016). Diagnosis and Management for ADHD: Clinical Practice Guideline (in Japanese). Jiho: Tokyo.
Thomas, R, Sanders, S, Doust, J, Beller, E, Glasziou, P (2015). Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 135, e994e1001.
Wang, LJ, Yang, KC, Lee, SY, Yang, CJ, Huang, TS, Lee, TL, Yuan, SS, Shyu, YC (2016). Initiation and persistence of pharmacotherapy for youths with attention deficit hyperactivity disorder in Taiwan. PLoS ONE 11, e0161061.
Wang, LJ, Lee, SY, Yuan, SS, Yang, CJ, Yang, KC, Huang, TS, Chou, WJ, Chou, MC, Lee, MJ, Lee, TL, Shyu, YC (2017). Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011. Epidemiology and Psychiatric Sciences 26, 624634.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed